Key result
Serum fibrinogen levels over 2.9 g/L linked to ~40% higher poststroke epilepsy risk.
Why the study?
The effect of circulating fibrinogen on cardiovascular and cerebrovascular diseases has been well studied, but its association with poststroke epilepsy has not.
Is circulating serum fibrinogen level associated with poststroke epilepsy within 1 year of acute ischemic stroke?
Observational (n=21,459)
Is circulating serum fibrinogen level associated with poststroke epilepsy within 1 year of acute ischemic stroke?
Answers are grounded in this paper and cite their sources.
Circulating serum fibrinogen levels exhibit a U-shaped association with the risk of poststroke epilepsy within 1 year of acute ischemic stroke, with a fold point at 2.9 g/L.
INTRODUCTION: As an indicator of coagulation function, the effect of circulating fibrinogen on cardiovascular and cerebrovascular diseases has been well studied, but the association between fibrinogen and poststroke epilepsy (PSE) has not. We explored the relationship between circulating serum fibrinogen levels and PSE events in a large sample of patients who had had an acute ischemic stroke in the past year. METHODS: We obtained from the Dryad database the medical records of 21 459 patients who had experienced an ischemic stroke to analyze the association between circulating fibrinogen level and PSE risk. RESULTS: Smooth curve analysis showed a U-shaped association between circulating fibrinogen level and PSE risk in the patients analyzed. The fold point of the circulating fibrinogen level for the association was 2.9 g/L. When fibrinogen levels were less than 2.9 g/L, an increase in fibrinogen contributed to a statistically significantly reduced risk of PSE events (odds ratio, 0.1 [95% CI, 0.1-0.2]; P < .001). In contrast, when fibrinogen levels were higher than 2.9 g/L, an increase in fibrinogen level was related to a higher risk of PSE events (odds ratio, 1.4 [95% CI, 1.2-1.7]; P < .001). DISCUSSION: Circulating serum fibrinogen level had a potential U-shaped association with PSE risk in a large-scale population of individuals who had had an acute ischemic stroke in the previous year.
No takes yet. Share an insight, caveat, or question.
Zheng et al. (2026) conducted an observational in Acute ischemic stroke (n=21,459). Circulating serum fibrinogen level was evaluated on Poststroke epilepsy (PSE) events (OR 1.4, 95% CI 1.2-1.7, p=<.001). Circulating serum fibrinogen levels exhibited a U-shaped association with poststroke epilepsy risk, where levels >2.9 g/L were associated with a higher risk.
Synapse has enriched 10 related papers. Consider them for comparative context: